Ethics bureaucracy: A significant hurdle for collaborative follow-up of drug effectiveness in rare childhood diseases

Archives of Disease in Childhood

Volumn 97, Issue 6, 2012, Pages 561-563

  Hansson, Mats G ^a   Gattorno, Marco ^b   Forsberg, Joanna Stjernschantz ^a   Feltelius, Nils ^c,d   Martini, Alberto ^b   Ruperto, Nicolino ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b G GASLINI INSTITUTE   (Italy)

^c MEDICAL PRODUCTS AGENCY   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL PRODUCT; CRYOPYRIN;

AUTOINFLAMMATORY DISEASE; CHILDHOOD DISEASE; CLINICAL TRIAL (TOPIC); COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; EDITORIAL; FOLLOW UP; JUVENILE RHEUMATOID ARTHRITIS; MEDICAL ETHICS; MEDICAL INFORMATION; MEDICAL RESEARCH; PRIORITY JOURNAL; RARE DISEASE; TISSUE INJURY;

CHILD; CLINICAL TRIALS AS TOPIC; ETHICS, MEDICAL; EUROPE; HUMANS; PEDIATRICS; RARE DISEASES; REGISTRIES;

EID: 84861480604     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/archdischild-2011-301175     Document Type: Editorial

References (15)

1. Ruperto N, Martini A. Use of unlabelled and off licence drugs in children. A European paediatric rule is needed to protect children. BMJ 2000;320:1210-11. (Pubitemid 30224281)
2. Regulation (EC) no 1901/2006 of the European parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004. Official Journal of the European Union. 2006;L378:1-19.
3. Food and Drug Administration (FDA). Regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biologic products in pediatrics patients (21 CFR Parts 201, 312, 314, and 601). Fed Regist 1998;63.
4. Ruperto N, Martini A. Networking in paediatrics: the example of the Paediatric Rheumatology International Trials Organisation (PRINTO). Arch Dis Child 2011;96:596-601.
5. European network of paediatric research (Enpr-EMA). Recognition criteria for self assessment. 2010. http://www.ema.europa.eu/docs/en-GB/document-library/ Other/2011/01/WC500100443.pdf (accessed 25 Jan 2012).
6. Report on second workshop of the European Paediatric Research Network (Enpr-EMA), 16 March 2010. http://www.ema.europa.eu/ema/index jsp?curl=pages/news-and-events/events/2010/02/event-detail-000173jsp&murl= menus/news-and-events/news-and- events jsp&mid=WC0b01ac058004d5c3 2010:1-8 (accessed 25 January 2012).
7. Ruperto N, Eichler I, Herold R, et al. A European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA). Arch Dis Child Published Online First: 27 November 2011 doi:10.1136/archdischild-2011-300286.
8. Ozen S, Frenkel J, Ruperto N, et al.; Eurofever Project. The Eurofever Project: towards better care for autoinflammatory diseases. Eur J Pediatr 2011;170:445-52.
9. Ruperto N, Lovell DJ, Quartier P, et al.; Paediatric Rheumatology International Trials Organization; Pediatric Rheumatology Collaborative Study Group. Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial. Lancet 2008;372:383-91.
10. Lovell DJ, Ruperto N, Goodman S, et al.; Pediatric Rheumatology Collaborative Study Group; Pediatric Rheumatology International Trials Organisation. Adalimumab with or without methotrexate in juvenile rheumatoid arthritis. N Engl J Med 2008;359:810-20.
11. Metcalfe C, Martin RM, Noble S, et al. Low risk research using routinely collected identifiable health information without informed consent: encounters with the Patient Information Advisory Group. J Med Ethics 2008;34:37-40.
12. Noble S, Donovan J, Turner E, et al. Feasibility and cost of obtaining informed consent for essential review of medical records in large-scale health services research. J Health Serv Res Policy 2009;14:77-81.
13. Hansson MG. Do we need a wider view of autonomy in epidemiological research? BMJ 2010;340:c.2335,1172-1174.
14. Whitney SN, Schneider CE. Viewpoint: a method to estimate the cost in lives of ethics board review of biomedical research. J Intern Med 2011;269:396-402.
15. Hansson MG, Chadwick R. Is medical ethics doing its job? J Intern Med 2011;269:366-9.